pyrroles has been researched along with Aspergillosis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Escribano, P; Gómez, A; Guinea, J; Muñoz, P; Reigadas, E | 1 |
Beckmann, N; Binder, U; Birch, M; Gould, J; Grässle, D; Lackner, M; Lass-Flörl, C; Law, D; Naschberger, V; Warn, P | 1 |
Beck, J; Broniszewska, M; Ebel, F; Heesemann, J; Jacobsen, ID; McCormick, A | 1 |
Dabur, R; Diwedi, SK; Mishra, V; Sharma, GL; Singh, H; Singh, R; Yadav, V | 1 |
Dabur, R; Mandal, TK; Sharma, GL | 1 |
5 other study(ies) available for pyrroles and Aspergillosis
Article | Year |
---|---|
In vitro activity of olorofim against Aspergillus fumigatus sensu lato clinical isolates: activity is retained against isolates showing resistance to azoles and/or amphotericin B.
Topics: Acetamides; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Fungal Proteins; Humans; Microbial Sensitivity Tests; Piperazines; Pyrimidines; Pyrroles | 2022 |
Dihydroorotate dehydrogenase inhibitor olorofim exhibits promising activity against all clinically relevant species within Aspergillus section Terrei.
Topics: Acetamides; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Dihydroorotate Dehydrogenase; Disease Models, Animal; Immunocompromised Host; Invasive Fungal Infections; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxidoreductases Acting on CH-CH Group Donors; Piperazines; Pyrimidines; Pyrroles | 2018 |
The two-component sensor kinase TcsC and its role in stress resistance of the human-pathogenic mold Aspergillus fumigatus.
Topics: Animals; Aspergillosis; Aspergillus fumigatus; Cyclic AMP; Dioxoles; Drug Resistance, Fungal; Fungal Proteins; Fungicides, Industrial; Histidine Kinase; Humans; Immunocompromised Host; Light; Mice; Microbial Sensitivity Tests; Models, Biological; Mutation; Phenotype; Phosphorylation; Protein Kinases; Pyrroles; Signal Transduction; Stress, Physiological; Virulence | 2012 |
Efficacy of 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrole-2-yl)-1-methylethyl pentanoate in a murine model of invasive aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cell Line; Dose-Response Relationship, Drug; Female; Macrophages; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pyrroles; Survival Rate; Valerates | 2005 |
Post-antifungal effects of the antifungal compound 2-(3,4-dimethyl-2,5-dihydro-1H-pyrrol-2-yl)-1-methylethyl pentanoate on Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Fungal Proteins; Humans; Metalloproteases; Molecular Weight; Pyrroles; Valerates; Virulence Factors | 2007 |